Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Roger Dansey
Age : 64
Public asset : 12,319,456 USD
Country of residence : Unknown
Linked companies : Seagen Inc. - Inovio Pharmaceuticals, Inc.

Biography of Roger Dansey 
Presently, Roger D. Dansey occupies the position of Chief Medical Officer for Seagen Inc. In the past Dr. Dansey held the position of Vice President-Oncology Clinical Research at Gilead Sciences, Inc. and SVP & Head-Therapeutic Area at Merck Research Laboratories Massachusetts LLC. Dr. Dansey received a doctorate from the University of the Witwatersrand.


Current positions of Roger Dansey 
Holdings of Roger Dansey 
Roger Dansey : Personal Network 
Most Read News 
01/04ELON MUSK : Musk-backed Starlink to refund pre-orders in India after govt order
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/07RICHARD BRANSON : British tycoon Branson to list blank-check firm in Amsterdam, Sky News says
RE
01/07TIM COOK : Tim Cook earned over 1,400 times the average Apple worker in 2021
RE
More news


© 2022 People and Ownership :   
Roger Dansey : Connections 


Latest news about Roger Dansey 
2021SEAGEN : Astellas Complete Enrollment in Cohort K of Study of Padcev, Keytruda Combination to Treat Urothelial Cancer
MT
2021Inovio Pharmaceuticals, Inc. Announces the Appointment of Roger Dansey to Its Board of Directors
CI
More news